Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Level II Quote: Ask side sparse after 24¢ level breached
View:
Post by VerusSemperSors on Nov 22, 2021 8:50am

Level II Quote: Ask side sparse after 24¢ level breached

Still plenty of shares available at 24¢. But not as many as on Friday. And if today's volume is anything like Friday we could blow throught the 24¢ level fast.

Last: 0.23   Change: 0.00   Volume: 0   Last Trade: 11/19

  Level ll Quote
  Bid   Ask
  Price   Total Size   # of Orders   Price   Total Size   # of Orders
$0.24 9500 3 $0.24 126000 3
$0.235 7500 3 $0.25 17500 2
$0.23 33500 3 $0.26 37000 3
$0.225 10000 1 $0.265 10000 1
$0.22 5000 1 $0.27 20000 4
$0.21 7500 1 $0.275 2500 1
$0.205 20000 2 $0.28 40000 1
$0.20 45000 2 $0.295 5000 1
$0.195 29000 2 $0.30 68500 4
$0.19 5000 1 $0.305 3500 1
Comment by robertshaw on Nov 22, 2021 9:13am
It seems blowjobjoe's bosses' resistance is 24, after that ,all the way to 30.
Comment by Lesalpes29 on Nov 22, 2021 9:58am
Could be for accumulation no?
Comment by robertshaw on Nov 22, 2021 10:03am
good idea of accumalation around this area before blewjobjoe's bosses cover their naked short for over 2 or 3 years
Comment by Lesalpes29 on Nov 22, 2021 10:16am
We have to team together and put bids at .24!
Comment by Lesalpes29 on Nov 22, 2021 10:25am
Added 16k at .24.
Comment by CAinPlap on Nov 22, 2021 10:39am
Hopefully the last available at .24. I'm showing ask at .245
Comment by Lesalpes29 on Nov 22, 2021 10:48am
Ready to add but I'm waiting. Need a sigh!
Comment by Galaxym31 on Nov 22, 2021 10:51am
We have been sighing for years .
Comment by Gooseybear on Nov 22, 2021 4:06pm
Not anymore. 
Comment by riverrrow on Nov 22, 2021 4:27pm
You're welcome.  I was happy to sell you some shares.  GLTA.
Theralase Technologies Inc.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250